Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,850
+140 (1.10%)
At close: May 12, 2025, 3:30 PM KST

KRX:007570 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
10,257-2,40919,38514,03210,880
Upgrade
Depreciation & Amortization
9,82411,97111,76711,22712,664
Upgrade
Other Amortization
---14.9920.03
Upgrade
Loss (Gain) From Sale of Assets
9.54-0.51-21.22-2.86-137.47
Upgrade
Asset Writedown & Restructuring Costs
-2.49-40.5125.51-263.191,947
Upgrade
Loss (Gain) From Sale of Investments
-27.43-30.5724.78-123.55
Upgrade
Loss (Gain) on Equity Investments
-2,08313,425-10,754-9,236-
Upgrade
Provision & Write-off of Bad Debts
-52.33-393.8-964.921,06798.4
Upgrade
Other Operating Activities
1,9013,6042,42716,8252,683
Upgrade
Change in Accounts Receivable
1,098-1,0873,101-10,2613,085
Upgrade
Change in Inventory
-7,606-5,574-16,8305,7195,929
Upgrade
Change in Accounts Payable
-3,545-3,4256,5024,160-1,746
Upgrade
Change in Income Taxes
----10,055
Upgrade
Change in Other Net Operating Assets
-4,157-1,421-8,77918,14711,883
Upgrade
Operating Cash Flow
5,61514,6195,88351,42957,484
Upgrade
Operating Cash Flow Growth
-61.59%148.49%-88.56%-10.53%58.83%
Upgrade
Capital Expenditures
-38,200-5,883-3,946-12,371-10,174
Upgrade
Sale of Property, Plant & Equipment
-0.52200.92-
Upgrade
Divestitures
----3,637
Upgrade
Sale (Purchase) of Intangibles
-2,423-949.74-12.08-2,128-14,447
Upgrade
Investment in Securities
3,365-4,60628,115-565.4-117.09
Upgrade
Other Investing Activities
82.53-77.65-14366.7-74.36
Upgrade
Investing Cash Flow
-37,175-11,51624,163-14,671-21,160
Upgrade
Short-Term Debt Issued
68,71624,78935,00039,147-
Upgrade
Long-Term Debt Issued
8,7006,000---
Upgrade
Total Debt Issued
77,41630,78935,00039,147-
Upgrade
Short-Term Debt Repaid
-42,000-30,000-56,500-31,147-13,412
Upgrade
Long-Term Debt Repaid
-717.18-2,753-3,737-10,758-12,506
Upgrade
Total Debt Repaid
-42,717-32,753-60,237-41,905-25,918
Upgrade
Net Debt Issued (Repaid)
34,699-1,965-25,237-2,758-25,918
Upgrade
Issuance of Common Stock
515.48----
Upgrade
Repurchase of Common Stock
--2,000-3,000--
Upgrade
Dividends Paid
-2,974-2,992-3,942-2,350-4,902
Upgrade
Other Financing Activities
-0.56-22183.5-31,524-141.56
Upgrade
Financing Cash Flow
32,240-6,978-31,996-36,632-30,961
Upgrade
Foreign Exchange Rate Adjustments
201.72115.33-164.64-82.48
Upgrade
Net Cash Flow
881.17-3,759-2,115125.495,446
Upgrade
Free Cash Flow
-32,5858,7361,93839,05747,310
Upgrade
Free Cash Flow Growth
-350.88%-95.04%-17.44%39.07%
Upgrade
Free Cash Flow Margin
-12.12%3.28%0.78%16.11%13.78%
Upgrade
Free Cash Flow Per Share
-1769.45475.15106.902145.402598.70
Upgrade
Cash Interest Paid
3,6343,3122,0961,9123,073
Upgrade
Cash Income Tax Paid
1,5981,2395,1081,32015,299
Upgrade
Levered Free Cash Flow
-37,19010,211-1,03734,08025,857
Upgrade
Unlevered Free Cash Flow
-35,35812,227295.8635,24927,722
Upgrade
Change in Net Working Capital
11,4333,14816,419-29,028-18,367
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.